1-Year Outcomes With Intracoronary  Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention

ConclusionsIn diabetic patients with STEMI, the administration of intracoronary abciximab improved the  effectiveness of primary PCI compared with the intravenous bolus.

Source: Journal of the American College of Cardiology - August 9, 2016 Category: Cardiology Source Type: research